SIMABS
Agoralaan, Abis Abis /
3590 Diepenbeek
BE
SIMABS
Foundation date
22/08/2019
Sector
#Biotechnology / R&D ServicesSubsector
- #Therapeutics - Biosimilars
- #Therapeutics - Nucleic acid drugs
- #Therapeutics - Proteins
- #R&D Services - Cell culture
- #R&D Services - CMO (Contract Manufacturing Organization)
- #R&D Services - Synthesis services
Therapeutic areas
SIMABS is a start-up biotechnology venture that wants to develop a new bio-manufacturing platform to provide cost effective therapeutic monoclonal antibodies at small scale to biopharmaceutical companies.
Upcoming events
All events-
0411 '24
BIO-Europe® 2024 - 30th Annual International Partnering Conference
Event by: EBD Group -
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
1610 '24
FIGON Dutch Medicines Days
Event by: Hyphen Projects
Latest news
More news-
Scientists discover viral trapdoor blocking HIV and herpes
1 day ago
Read more
-
UZ Leuven and KU Leuven invest 14 million euro in new cell and gene therapy facility
Tuesday October 8th 2024
Read more
-
Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth
Monday October 7th 2024
Read more
Jobs by SIMABS
More jobsMore info?
Contact us
Ellen Telleir
Communication Coordinator